SMA TYPE I , II, III – Clinical Trials with RG7916

Spinraza was the beginning. Roche is in the development of a small molecule named RG7916 a new therapy for SMA. ‘Hope with Roche #SMA #SpinalMuskelAtrofi ▶ Clinical Trials with RG7916 by Roche PDF Datei FIREFISH TRIAL FOR SMA TYPE 1 https://www.pioneeringhealthcare.com/sma/clinical-trial-sma-type-1/ A NEW TOOL FOR TRACKING THE PROGRESSION OF SPINAL … Fortsätt läsa SMA TYPE I , II, III – Clinical Trials with RG7916